Chinese english Germany Japanese Korea

aspergillimide

aspergillimide Struktur
195966-93-9
CAS-Nr.
195966-93-9
Englisch Name:
aspergillimide
Synonyma:
aspergillimide;(rel)-Asperparaline A;Spiro[5H,6H-5a,9a-(iminomethano)-1H-cyclopent[f]indolizine-7(8H),3'-pyrrolidine]-2',5',10-trione, tetrahydro-1,1',8,8,11-pentamethyl-, (1R,3'R,5aR,8aR,9aS)-rel-(-)-
CBNumber:
CB51371818
Summenformel:
C20H29N3O3
Molgewicht:
359.46256
MOL-Datei:
195966-93-9.mol
Request For Quotation

aspergillimide Eigenschaften

Siedepunkt:
546.1±50.0 °C(Predicted)
Dichte
1.30±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO: soluble; Ethanol: soluble; Methanol: soluble
Aggregatzustand
A solid
pka
8.68±0.60(Predicted)
Farbe
White

Sicherheit

aspergillimide Chemische Eigenschaften,Einsatz,Produktion Methoden

aspergillimide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

aspergillimide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		+16314854226
 inquiry@bocsci.com United States 19743 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
 info@efebio.com China 9709 58
Shanghai Hongye Biotechnology Co. Ltd 400-9205774
sales@glpbio.cn China 6870 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
 sales@chemegen.com China 11289 58
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628
 jiangnan@huidabiotech.com China 3661 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369
3477467573@qq.com China 8618 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840
psaitong@jm-bio.com China 29778 58
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639
 sunshixuan@huidabiotech.com China 3705 58
  • aspergillimide
  • Spiro[5H,6H-5a,9a-(iminomethano)-1H-cyclopent[f]indolizine-7(8H),3'-pyrrolidine]-2',5',10-trione, tetrahydro-1,1',8,8,11-pentamethyl-, (1R,3'R,5aR,8aR,9aS)-rel-(-)-
  • (rel)-Asperparaline A
  • 195966-93-9
Copyright 2019 © ChemicalBook. All rights reserved